کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8818660 | 1609083 | 2018 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014
ترجمه فارسی عنوان
سرپایی، استفاده ترکیبی از داروهای مخدر و بنزودیازپین در ایالات متحده، 1993-2014
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
CDCICD-9-CMNCHSNAMCSRfVOpioid - opioidMedication safety - ایمنی داروbenzodiazepine - بنزودیازپینPain - دردinternational classification of diseases, ninth revision, clinical modification - طبقه بندی بین المللی بیماری ها، اصلاح نهم، اصلاح بالینیconfidence interval - فاصله اطمینانNational Ambulatory Medical Care Survey - مراقبتهای بهداشتی درمانی ملیCenters for Disease Control and Prevention - مراکز کنترل و پیشگیری از بیماریNational Center for Health Statistics - مرکز ملی آمار بهداشتodds ratio - نسبت شانس هاPrescriptions - نسخه ها
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
سیاست های بهداشت و سلامت عمومی
چکیده انگلیسی
The combined use of opioid and benzodiazepine medications increases the risk of hazardous effects, such as respiratory depression. Although recent increases in outpatient use of opioid prescriptions have been documented, there are limited data regarding rates and correlates of combined opioid and benzodiazepines among adults in outpatient settings. Our objective was to examine annual trends in outpatient visits including opioids, benzodiazepines, and their combination among adults as well as clinical and demographic correlates. We used data from the 1993-2014 National Ambulatory Medical Care Survey (NAMCS) among non-elderly (i.e., ages 18-64Â years) adults to examine the probability of a visit including an opioid, benzodiazepine, or their combination, in addition to clinical and demographic correlates. From 1993 to 2014, benzodiazepines-with-opioids visits increased from 9.8 to 62.5 (ORÂ =Â 9.23, 95% CIÂ =Â 5.45-15.65) per 10,000 visits. Highest-represented groups among benzodiazepines-with-opioids visits were older (50-64Â years) (49.1%), white (88.8%), commercially insured (58.0%) patients during their first visit (87.6%) to a primary-care physician (41.9%). We identified a significant increase in the outpatient co-prescription of opioids and benzodiazepines, notably among adults aged 50-64Â years during primary-care visits. Educational and policy changes to provide alternatives to benzodiazepine-with-opioid co-prescription and limiting opioid prescription to pain specialists may reduce rates of this potentially hazardous combination.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Preventive Medicine Reports - Volume 9, March 2018, Pages 49-54
Journal: Preventive Medicine Reports - Volume 9, March 2018, Pages 49-54
نویسندگان
Matthew E. Hirschtritt, Kevin L. Delucchi, Mark Olfson,